0001179110-18-011383.txt : 20180913 0001179110-18-011383.hdr.sgml : 20180913 20180913181335 ACCESSION NUMBER: 0001179110-18-011383 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180911 FILED AS OF DATE: 20180913 DATE AS OF CHANGE: 20180913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rabinowitz Matthew CENTRAL INDEX KEY: 0001646382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 181069765 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 edgar.xml FORM 4 - X0306 4 2018-09-11 0 0001604821 Natera, Inc. NTRA 0001646382 Rabinowitz Matthew C/O NATERA, INC., 201 INDUSTRIAL ROAD SUITE 410 SAN CARLOS CA 94070 1 1 0 0 Chief Executive Officer Common Stock 2018-09-11 4 S 0 183763 25.1252 D 1701686 D Common Stock 2018-09-11 4 S 0 1400 25.5964 D 1700286 D Common Stock 2018-09-12 4 S 0 53826 24.8705 D 1646460 D Common Stock 2018-09-13 4 S 0 104371 24.2576 D 1542089 D Common Stock 2018-09-13 4 S 0 60102 25.3441 D 1481987 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.57 to $25.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.80 to $25.62 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.56 to $25.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.17 to $25.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.17 to $25.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Tami Chen, attorney-in-fact 2018-09-13